TITLE

BENEFITS OF LIFESTYLE MODIFICATION IN NAFLD

AUTHOR(S)
Harrison, Stephen A.; Day, Christopher Paul
PUB. DATE
December 2007
SOURCE
Gut;Dec2007, Vol. 56 Issue 12, p1760
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article reports on the significance of enhancing the dietary and exercise practices of patients suffering from non-alcoholic fatty liver disease (NAFLD). It states that poor diet and exercise contribute to the disregulation of energy metabolism, obesity and NAFLD. In addition, high sugar intake also results to the development of hepatic steatosis. However, a study reveals that lifestyle modifications which focuses on enhancing exercise and diet can help prevent the development of NAFLD.
ACCESSION #
28105590

 

Related Articles

  • Effectiveness of antiplatelet drugs against experimental non-alcoholic fatty liver disease. Fujita, K.; Nozaki, Y.; Wada, K.; Yoneda, M.; Endo, H.; Takahashi, H.; Iwasaki, I.; Inamori, M.; Abe, Y.; Kobayashi, N.; Kirikoshi, H.; Kubota, K.; Saito, S.; Nagashima, Y.; Nakajima, A. // Gut;Nov2008, Vol. 57 Issue 11, p1583 

    Objective: No effective drugs have been developed to date to prevent or treat non-alcoholic fatty liver disease (NAFLD), although diet modification and exercise to improve obesity have been attempted. Therefore, development of a novel drug/strategy to treat NAFLD is urgently needed. In the...

  • The effect of a low-carbohydrate diet on the nonalcoholic fatty liver in morbidly obese patients before bariatric surgery. Benjaminov, O.; Beglaibter, N.; Gindy, L.; Spivak, H.; Singer, P.; Wienberg, M.; Stark, A.; Rubin, M. // Surgical Endoscopy;Aug2007, Vol. 21 Issue 8, p1423 

    Bariatric surgery may be complicated by enlargement of the liver, especially of the left lobe, caused by nonalcoholic fatty liver disease often present with morbid obesity. The effect of a very low carbohydrate diet for 4 weeks before surgery on liver density and volume was assessed in 14...

  • Exercise and the fatty liver. Spassiani, Natasha A.; Kuk, Jennifer L. // Applied Physiology, Nutrition & Metabolism;Aug2008, Vol. 33 Issue 4, p802 

    Fatty liver is an increasingly prevalent condition that is associated with several metabolic derangements, thus necessitating the development of effective therapeutic interventions. Growing evidence from cross-sectional studies suggest that physical activity may be a promising therapy for fatty...

  • NAFLD and Insulin Resistance Do Not Increase the Risk of Postoperative Complications Among Patients Undergoing Bariatric Surgery-A Prospective Analysis. Ribeireiro, Tarsila; Swain, James; Sarr, Michael; Kendrick, Michael; Que, Florencia; Sanderson, Schuyler; Krishnan, Anuradha; Viker, Kimberly; Watt, Kymberly; Charlton, Michael // Obesity Surgery;Mar2011, Vol. 21 Issue 3, p310 

    Background: Nonalcoholic fatty liver disease (NAFLD) and insulin resistance are common consequences of obesity and are highly prevalent among patients undergoing bariatric surgery. Insulin resistance and NAFLD have been reported to be associated with postoperative complications following major...

  • Possible molecular mechanisms soy-mediated in preventing and treating nonalcoholic fatty liver disease. Oliveira, L. P. M.; de Jesús, R. P.; Freire, T. O.; Oliveira, C. P.; Lyra, A. Castro; Lyra, L. G. C. // Nutricion Hospitalaria;2012, Vol. 27 Issue 4, p991 

    The aim of this review is to describe the molecular mechanisms of nonalcoholic fatty liver disease (NAFLD) and to present evidence regarding the mechanisms of soy-mediated therapeutic activity in preventing and treating NAFLD. NAFLD is induced by multiple metabolic path- ways, including an...

  • Ablation of PI3K p 110-α Prevents High-Fat Diet-Induced Liver Steatosis. Chattopadhyay, Mohar; Selinger, Elzbieta S.; Ballou, Lisa M.; Lin, Richard Z. // Diabetes;May2011, Vol. 60 Issue 5, p1483 

    OBJECTIVE--To determine whether the phosphoinositide 3-kinase (PI3K) catalytic subuniLs p110-α and p110-β play a role in liver steatosis induced by a high-fat diet (HFD). RESEARCH DESIGN AND METHODS--Liver-specific p110-α and p110-β knockout mice and control animals for each group...

  • The Effects of Rosiglitazone, Metformin, and Diet with Exercise in Nonalcoholic Fatty Liver Disease. Kadir Demir; Sadakat Özdil; Nevzat Aksoy; Şule Poturoğlu; Duygu Ä°brişim; Sabahattin Kaymakoğlu; Fatih Beşışık; Güngör Boztaş; Yılmaz Çakaloğlu; Zeynel Mungan; Uğur Çevikbaş; Atilla Ökten // Digestive Diseases & Sciences;Sep2007, Vol. 52 Issue 9, p2359 

    Abstract  Our aım was to evaluate effects of metformin, rosiglitazone, and diet with exercise in nonalcoholic fatty liver disease. Forty-seven patients (mean age, 44�10 years; 17 female) whose ALT levels had been high for at least 6 months and with...

  • A LIPIDOMIC READOUT OF DISEASE PROGRESSION IN A DIET-INDUCED MOUSE MODEL OF NONALCOHOLIC FATTY LIVER DISEASE. SANYAL, ARUN J.; PACANA, TOMMY // Transactions of the American Clinical & Climatological Associati;2015, Vol. 126, p271 

    Multiple changes in lipid metabolism occur in nonalcoholic fatty liver disease. However, it is not known which of these contribute to disease progression. The objective of this study was to define changes in hepatic lipid composition over time in a diet-induced model of nonalcoholic fatty liver...

  • Correction: Mouse Models of Diet-Induced Nonalcoholic Steatohepatitis Reproduce the Heterogeneity of the Human Disease. Machado, Mariana Verdelho; Michelotti, Gregory Alexander; Xie, Guanhua; de Almeida, Thiago Pereira; Boursier, Jerome; Bohnic, Brittany; Guy, Cynthia D.; Diehl, Anna Mae // PLoS ONE;Jun2015, Vol. 10 Issue 6, p1 

    No abstract available.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics